EEG University

NCSE and the Impact of Rapid EEG

Dr. Josef Parvizi, Stanford University Medical Center; Dr. Paul Vespa, David Geffen School of Medicine, UCLA; and Ms. Mary Kay Bader, Mission Hospital

Josef Parvizi, Mary Kay Bader and Paul Vespa discuss the need and impact of Rapid EEG

Josef Parvizi, MD, PhD is a Professor of Neurology and Neurological Sciences at Stanford University Medical Center. He has extensively published original scientific works and is the co-founder and inventor of Ceribell Rapid Response EEG.

Paul M. Vespa, MD, FCCM, FAAN, FANA, FNCS is the Assistant Dean of Critical Care Medicine, Research and David Geffen School of Medicine, UCLA and Gary L. Brinderson Family Chair in Neurocritical Care at David Geffen School of Medicine, UCLA. He directs research in traumatic brain injury and neurocritical care at UCLA and has been committed to studying brain metabolism, neurochemistry and electrophysiology in TBI. Dr. Vespa has published over 200 manuscripts and is an editorial board member for several international journals.

Mary Kay Bader has 42 years experience with an emphasis in neuroscience/ICU. She has lectured nationally and internationally on traumatic brain injury (TBI), hypothermia and targeted temperature management (TTM), intracranial pressure (ICP), spinal cord injury, aneurysmal subarachnoid hemorrhage (SAH), novel anticoagulants in the presence of intracranial hemorrhage and stroke. Mary Kay was honored as a Fellow for NCS in October 2013 and currently sits on the Board of Directors. She is also a past President of NCS and of AANN.